Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation.

Lamprecht P, Humrich JY, Diebold I, Riemekasten G.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):177. Epub 2018 Mar 15. No abstract available.

2.

Extension of the phenotype of biallelic loss-of-function mutations in SLC25A46 to the severe form of pontocerebellar hypoplasia type I.

Braunisch MC, Gallwitz H, Abicht A, Diebold I, Holinski-Feder E, Van Maldergem L, Lammens M, Kovács-Nagy R, Alhaddad B, Strom TM, Meitinger T, Senderek J, Rudnik-Schöneborn S, Haack TB.

Clin Genet. 2018 Feb;93(2):255-265. doi: 10.1111/cge.13084. Epub 2017 Nov 8.

PMID:
28653766
3.

In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.

Hopper RK, Moonen JR, Diebold I, Cao A, Rhodes CJ, Tojais NF, Hennigs JK, Gu M, Wang L, Rabinovitch M.

Circulation. 2016 May 3;133(18):1783-94. doi: 10.1161/CIRCULATIONAHA.115.020617. Epub 2016 Apr 4.

4.

BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension.

Diebold I, Hennigs JK, Miyagawa K, Li CG, Nickel NP, Kaschwich M, Cao A, Wang L, Reddy S, Chen PI, Nakahira K, Alcazar MA, Hopper RK, Ji L, Feldman BJ, Rabinovitch M.

Cell Metab. 2015 Apr 7;21(4):596-608. doi: 10.1016/j.cmet.2015.03.010.

5.

Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

Nickel NP, Spiekerkoetter E, Gu M, Li CG, Li H, Kaschwich M, Diebold I, Hennigs JK, Kim KY, Miyagawa K, Wang L, Cao A, Sa S, Jiang X, Stockstill RW, Nicolls MR, Zamanian RT, Bland RD, Rabinovitch M.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1273-86. doi: 10.1164/rccm.201412-2291OC.

6.

NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Kleikers PW, Wingler K, Hermans JJ, Diebold I, Altenhöfer S, Radermacher KA, Janssen B, Görlach A, Schmidt HH.

J Mol Med (Berl). 2012 Dec;90(12):1391-406. doi: 10.1007/s00109-012-0963-3. Epub 2012 Oct 23. Review.

PMID:
23090009
7.

The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II.

Diebold I, Petry A, Sabrane K, Djordjevic T, Hess J, Görlach A.

J Cell Sci. 2012 Feb 15;125(Pt 4):956-64. doi: 10.1242/jcs.094060. Epub 2012 Mar 7.

8.

STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.

Grunewald TG, Diebold I, Esposito I, Plehm S, Hauer K, Thiel U, da Silva-Buttkus P, Neff F, Unland R, Müller-Tidow C, Zobywalski C, Lohrig K, Lewandrowski U, Sickmann A, Prazeres da Costa O, Görlach A, Cossarizza A, Butt E, Richter GH, Burdach S.

Mol Cancer Res. 2012 Jan;10(1):52-65. doi: 10.1158/1541-7786.MCR-11-0524. Epub 2011 Nov 11.

9.

NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.

Diebold I, Petry A, Burger M, Hess J, Görlach A.

Mol Biol Cell. 2011 Nov;22(22):4424-34. doi: 10.1091/mbc.E10-12-0971. Epub 2011 Sep 30.

10.

PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer.

Su Y, Loos M, Giese N, Hines OJ, Diebold I, Görlach A, Metzen E, Pastorekova S, Friess H, Büchler P.

Br J Cancer. 2010 Nov 9;103(10):1571-9. doi: 10.1038/sj.bjc.6605936. Epub 2010 Oct 26.

11.

The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.

Diebold I, Petry A, Hess J, Görlach A.

Mol Biol Cell. 2010 Jun 15;21(12):2087-96. doi: 10.1091/mbc.E09-12-1003. Epub 2010 Apr 28.

12.

The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4.

Diebold I, Flügel D, Becht S, Belaiba RS, Bonello S, Hess J, Kietzmann T, Görlach A.

Antioxid Redox Signal. 2010 Aug 15;13(4):425-36. doi: 10.1089/ars.2009.3014.

PMID:
20039838
13.

Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling.

Diebold I, Petry A, Djordjevic T, Belaiba RS, Fineman J, Black S, Schreiber C, Fratz S, Hess J, Kietzmann T, Görlach A.

Antioxid Redox Signal. 2010 Aug 15;13(4):399-412. doi: 10.1089/ars.2009.3013.

PMID:
20001745
14.

Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2.

Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, Görlach A.

Circ Res. 2009 May 22;104(10):1169-77. doi: 10.1161/CIRCRESAHA.109.196592. Epub 2009 Apr 23.

16.

The 'PAI-1 paradox' in vascular remodeling.

Diebold I, Kraicun D, Bonello S, Görlach A.

Thromb Haemost. 2008 Dec;100(6):984-91. Review.

PMID:
19132221
17.

NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells.

Herkert O, Diebold I, Brandes RP, Hess J, Busse R, Görlach A.

Circulation. 2002 Apr 30;105(17):2030-6.

18.

Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase.

Görlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R.

Circ Res. 2001 Jul 6;89(1):47-54.

Supplemental Content

Loading ...
Support Center